Dushime, Honorine
Moreno, Stéphanie G.
Linard, Christine
Adrait, Annie
Couté, Yohann
Peltzer, Juliette
Messiaen, Sébastien
Torres, Claire
Bensemmane, Lydia
Lewandowski, Daniel
Romeo, Paul-Henri
Petit, Vanessa http://orcid.org/0000-0001-6233-1946
Gault, Nathalie
Funding for this research was provided by:
Institut de Radioprotection et de SÛreté Nucléaire
Commissariat à l'Énergie Atomique et aux Énergies Alternatives
Article History
Received: 21 October 2022
Accepted: 21 July 2023
First Online: 11 August 2023
Declarations
:
: All experiment procedures in this study were approved and performed in accordance with the guidelines of the French Ministry of Agriculture’s Animal Ethics Committee (EC Directive 2010/63/EU and French Decree 2013–118). The use of animals has been approved by an IRSN ethics committee (CEEA 546 Number 81 for IRSN unit). The approved project is: Evaluation of the therapeutic efficacy of MUSE cells in the management of radio-induced gastrointestinal syndrome in mice; IRSN project P18-11, Approval number: APAFIS#17492-2018111211126943-v1, 01/10/2019. The manuscript adheres to the ARRIVE guidelines (ExternalRef removed) for the reporting of animal experiments.
: Not applicable in this section.
: The authors declare that they have no competing interest.